Dashboard
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of 13.50% and Operating profit at -5.58% over the last 5 years
3
Positive results in Mar 25
4
Risky -
5
Market Beating Performance
Stock DNA
Media & Entertainment
CNY 2,976 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.13
-10.02%
2.88
Revenue and Profits:
Net Sales:
40 Million
(Quarterly Results - Jun 2025)
Net Profit:
-6 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.0%
0%
4.0%
6 Months
36.44%
0%
36.44%
1 Year
126.09%
0%
126.09%
2 Years
-41.06%
0%
-41.06%
3 Years
-66.4%
0%
-66.4%
4 Years
-42.86%
0%
-42.86%
5 Years
1.52%
0%
1.52%
Qinghai Spring Medicinal Resources Technology Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.50%
EBIT Growth (5y)
-5.58%
EBIT to Interest (avg)
-164.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.18
Tax Ratio
5.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.88
EV to EBIT
-25.94
EV to EBITDA
-37.23
EV to Capital Employed
3.16
EV to Sales
11.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-12.19%
ROE (Latest)
-10.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
39.90
82.00
-51.34%
Operating Profit (PBDIT) excl Other Income
4.80
13.70
-64.96%
Interest
0.10
0.10
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-6.20
9.00
-168.89%
Operating Profit Margin (Excl OI)
-77.80%
71.30%
-14.91%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -51.34% vs 15.66% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -168.89% vs 108.28% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
265.40
210.20
26.26%
Operating Profit (PBDIT) excl Other Income
-121.80
-90.30
-34.88%
Interest
1.00
1.00
Exceptional Items
-44.80
-23.00
-94.78%
Consolidate Net Profit
-197.30
-266.20
25.88%
Operating Profit Margin (Excl OI)
-585.50%
-571.40%
-1.41%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 26.26% vs 33.97% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 25.88% vs 7.44% in Dec 2023
About Qinghai Spring Medicinal Resources Technology Co. Ltd. 
Qinghai Spring Medicinal Resources Technology Co. Ltd.
Media & Entertainment
No Details Available.
Company Coordinates 
No Company Details Available






